Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02569892 · ClinicalTrials.gov registry record · NA
Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02569892: Completed NA study, sponsored by Stanford University.
NCT02569892 is a NA study that has completed, run by Stanford University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02569892, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is a randomized controlled study of non-damaging photothermal macular grid laser versus sham laser therapy in patients with dry age-related macular degeneration (AMD) and large high-risk drusen. The goal of the study is to determine if this treatment will reduce macular drusen volume and also whether this might improve visual acuity or reduce the risk of conversion to advanced age-related macular degeneration defined as development of choroidal neovascularization or geographic atrophy.
Interventions
- DEVICE Pascal Retinal Laser Photocoagulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2021-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02569892
The ClinicalTrials.gov registry entry for NCT02569892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pascal Retinal Laser Photocoagulator is the first listed.
NCT02569892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02569892 about?
NCT02569892 is a clinical study titled "Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration". This is a randomized controlled study of non-damaging photothermal macular grid laser versus sham laser therapy in patients with dry age-related macular degeneration (AMD) and large high-risk drusen. The goal of the study is to determine if this treatment will reduce macular drusen volume and also w...
What is the current status of trial NCT02569892?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2016-09-01. Estimated completion is 2021-01-25.
What interventions are being tested in trial NCT02569892?
The interventions under investigation include: Pascal Retinal Laser Photocoagulator (DEVICE).
Who is sponsoring clinical trial NCT02569892?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.